![HeartSciences MyoVista wavECG User Manual Download Page 131](http://html.mh-extra.com/html/heartsciences/myovista-wavecg/myovista-wavecg_user-manual_2114879131.webp)
122
USER MANUAL DO-LBL-06035(L)
| MyoVista® Wavelet ECG (
wav
ECG™) 12-Lead Cardiac Testing Device
Table E-2 . Summarizes the relative-risk measures for the Ischemic or Structural Risk assessment statements .
Table E-2
Ischemic or Structural
Risk assessment
statement
Sex
Relative-Risk
(n=210)
Inconclusive Ischemic
or Structural Risk
Assessment
Combined
Criteria resulted in statistically insignificant measures.
(p-value is >0 .05)
Men
Women
Possible Ischemic or
Structural Abnormality
(compared to
Categorization of
“Normal”)
Combined
2 .92X
95% CI [1 .81, 4 .72]
p-value: <0 .0001
Men
4 .77X
95% CI [2 .05, 11 .06]
p-value: 0 .0003
Women
1 .62X
95% CI [0 .76, 3 .47]
p-value is 0 .2155
Probable Ischemic or
Structural Abnormality
(compared to
Categorization of
“Normal”)
Combined
3 .89X
95% CI [2 .47, 6 .11]
p-value: <0 .0001
Men
6 .73X
95% CI [2 .95, 15 .36]
p-value: <0 .0001
Women
2 .73X
95% CI [1 .57, 4 .76]
p-value: 0 .0004
Appendix E: MyoVista
wav
ECG Information, Measures Development and Statistical Performance